Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Gabup
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Gabup 0.4mg sublingual tablets
0410030A0BEAFAC
|
Gabup | Buprenorphine hydrochloride | Central Nervous System | No data available |
|
Gabup 1mg sublingual tablets
0410030A0BEACAI
|
Gabup | Buprenorphine hydrochloride | Central Nervous System | No data available |
|
Gabup 2mg sublingual tablets
0410030A0BEAAAD
|
Gabup | Buprenorphine hydrochloride | Central Nervous System | No data available |
|
Gabup 4mg sublingual tablets
0410030A0BEAEAK
|
Gabup | Buprenorphine hydrochloride | Central Nervous System | No data available |
|
Gabup 6mg sublingual tablets
0410030A0BEADAJ
|
Gabup | Buprenorphine hydrochloride | Central Nervous System | No data available |
|
Gabup 8mg sublingual tablets
0410030A0BEABAE
|
Gabup | Buprenorphine hydrochloride | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.